Dr Matera explains the importance of treating hyperkalemia – a common occurrence in patients with chronic kidney disease – in the context of comorbid cardiometabolic disease.
Dr Matera discusses common concerns and questions patients with chronic kidney disease ask their physicians, as well as the importance of collaboration between nephrologists and primary care physicians in managing this condition.
Considering pharmacotherapy for your patient with obesity? Here’s what you should know, according to Dr Harold Bays, who presented “Current and Future of Obesity Drug Therapies: Echoes of Today’s Metabolic Treatments” at the 2018 Cardiometabolic Risk Summit.
“Primary care providers are increasingly called upon to recognize and treat heart failure early in their patients”, said Dr Keith C. Ferdinand during his presentation at CRS 2018, “Update in the Management of Heart Failure: A Practical, Guideline-Directed Approach.”
Dr. James Matera, nephrologist and co-director of physician integration, answers questions about cardiometabolic risk in the United States as well as management of patients with chronic kidney disease.
Dr. James R. Gavin III, professor of medicine at the Morehouse School of Medicine in Atlanta, Georgia, answers questions about managing patients with cardiometabolic disease, especially those with diabetes in rural locations.
Dr. Donna H. Ryan, the executive director at Pennington Biomedical Research Center in Baton Rouge, Louisiana, discusses managing and treating patients with cardiometabolic disease, and specifically those with obesity.